Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

This study has been completed.
Sponsor:
Information provided by:
The Medicines Company
ClinicalTrials.gov Identifier:
NCT00093158
First received: October 4, 2004
Last updated: August 20, 2007
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given
No publications provided by The Medicines Company

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):